FDA Warning Letter — Novel Laboratories, Inc. d.b.a Lupin Somerset
The FDA took a Warning Letter action against Novel Laboratories, Inc. d.b.a Lupin Somerset on June 11, 2021 (Somerset, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Novel Laboratories, Inc. d.b.a Lupin Somerset
- Date
- June 11, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Center
- CDER
- Location
- Somerset, NJ (United States)